SCHEMBL1709974

SCHEMBL1709974

CNC(=O)NCCc1ccc(O)c(O)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 6/20 0.71
HSD17B10 Q99714 3/20 0.71
ALDH1A1 P00352 3/20 0.71
HIF1A Q16665 2/20 0.71
KDM4E B2RXH2 2/20 0.71
LMNA P02545 2/20 0.71
HPGD P15428 2/20 0.71
BLM P54132 2/20 0.71
PTGS1 P23219 1/20 0.71
TP53 P04637 1/20 0.64
CYP1A2 P05177 1/20 0.64
ALOX15 P16050 1/20 0.64
TSHR P16473 1/20 0.64
NFKB1 P19838 1/20 0.64
MAPK1 P28482 1/20 0.64
THPO P40225 1/20 0.64
GMNN O75496 1/20 0.62
GFER P55789 1/20 0.62
PMP22 Q01453 1/20 0.62
SMN1; SMN2 Q16637 1/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7105545 0.90 MAPT (0.74) MAPTHSD17B10ALDH1A1HIF1AKDM4E
SCHEMBL138689 0.83 MAPT (0.66) MAPTHSD17B10ALDH1A1HIF1AKDM4E
SCHEMBL30252290 0.83 MAPT (0.66) MAPTHSD17B10ALDH1A1HIF1AKDM4E
SCHEMBL30616852 0.83 MAPT (1.00) MAPTHSD17B10ALDH1A1HIF1AKDM4E
SCHEMBL328568 0.83 MAPT (1.00) MAPTHSD17B10ALDH1A1HIF1AKDM4E
SCHEMBL109163 0.82 MAPT (0.74) MAPTHSD17B10ALDH1A1HIF1AKDM4E
Water SCHEMBL1321161 0.81 MAPT (0.97) MAPTHSD17B10ALDH1A1HIF1AKDM4E
Potassium SCHEMBL29870134 0.81 MAPT (0.97) MAPTHSD17B10ALDH1A1HIF1AKDM4E
SCHEMBL29870429 0.81 MAPT (0.97) MAPTHSD17B10ALDH1A1HIF1AKDM4E
Hydrochloric Acid SCHEMBL28839145 0.81 MAPT (0.97) MAPTHSD17B10ALDH1A1HIF1AKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230355843-A1 INJECTABLE CUSHIONING HYDROGELS SUPRA B B.V. (NL) 2023-11-09 US disclosed
US-20230012485-A1 ADHESIVE DEVICE FOR BIOMEDICAL APPLICATIONS AND METHODS OF USE THEREOF SUNNYBROOK HEALTH SCIENCES CENTRE (CA) 2023-01-19 US disclosed
US-20230001046-A1 BIOCOMPATIBLE ADHESIVES AND METHODS OF MANUFACTURE THEREOF GOVERNING COUNCIL UNIV TORONTO (CA) 2023-01-05 US disclosed
EP-2102319-B1 ULTRA-THIN WATER AND OIL REPELLENT LAYER, MANUFACTURING METHOD AND USE IN MECHANICS AS A BARRIER FILM SUSOS AG (CH) 2017-03-29 EP disclosed
EP-2084253-B1 ULTRA-THIN WATER AND OIL REPELLENT LAYER, MANUFACTURING METHOD AND USE IN WATCHMAKING AS EPILAME ROLEX SA (CH) 2017-03-29 EP disclosed
EP-2084252-B1 ULTRA-THIN WATER AND OIL REPELLENT LAYER, MANUFACTURING METHOD AND USE IN WATCHMAKING AS EPILAME ROLEX SA (CH) 2017-03-29 EP disclosed
US-8951630-B2 Ultra-thin hydrophobic and oleophobic layer, method of manufacture and use in watchmaking as an epilame and in mechanical engineering as a barrier film ROLEX S.A. (CH) 2015-02-10 US disclosed
US-20120088099-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, METHOD OF MANUFACTURE AND USE IN WATCHMAKING AS AN EPILAME AND IN MECHANICAL ENGINEERING AS A BARRIER FILM SUSOS AG (CH) 2012-04-12 US disclosed
US-20100098926-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, ITS METHOD OF MANUFACTURE AND USE IN MECHANICS AS A BARRIER FILM SUSOS AG (CH) 2010-04-22 US disclosed
US-20100098926-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, ITS METHOD OF MANUFACTURE AND USE IN MECHANICS AS A BARRIER FILM SUSOS AG (CH) 2010-04-22 US disclosed
US-20100075138-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, METHOD OF MANUFACTURE AND USE IN WATCHMAKING AS AN EPILAME ROLEX S.A. (CH) 2010-03-25 US disclosed
US-20100075138-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, METHOD OF MANUFACTURE AND USE IN WATCHMAKING AS AN EPILAME ROLEX S.A. (CH) 2010-03-25 US disclosed
US-20100068553-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, METHOD OF MANUFACTURE AND USE IN WATCHMAKING AS AN EPILAME ROLEX S.A. (CH) 2010-03-18 US disclosed
US-20100068553-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, METHOD OF MANUFACTURE AND USE IN WATCHMAKING AS AN EPILAME ROLEX S.A. (CH) 2010-03-18 US disclosed
WO-2008064513-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, ITS METHOD OF MANUFACTURE AND USE IN MECHANICS AS A BARRIER FILM SUSOS AG (CH) 2008-06-05 WO disclosed
WO-2008064511-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, ITS METHOD OF MANUFACTURE AND USE IN CLOCKMAKING AS AN EPILAME ROLEX S.A. (CH) 2008-06-05 WO disclosed
WO-2008064512-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, ITS METHOD OF MANUFACTURE AND USE IN MECHANICS AS A BARRIER FILM SUSOS AG (CH) 2008-06-05 WO disclosed
WO-2008064510-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, ITS METHOD OF MANUFACTURE AND USE IN CLOCKMAKING AS AN EPILAME ROLEX S.A. (CH) 2008-06-05 WO disclosed
EP-1927649-A1 Ultra-thin water and oil repellent layer, manufacturing method and use in mechanics as a barrier film SurfaceSolutions GmbH (CH) 2008-06-04 EP disclosed
EP-1927648-A1 Ultra-thin water and oil repellent layer, manufacturing method and use in watchmaking as epilame ROLEX SA (CH) 2008-06-04 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100075138-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, METHOD OF MANUFACTURE AND USE IN WATCHMAKING AS AN EPILAME KCNH3, HCN3, HCN4 MAPT 4234/4885HSD17B10 2782/4885ALDH1A1 3264/4885
US-20100068553-A1 ULTRA-THIN HYDROPHOBIC AND OLEOPHOBIC LAYER, METHOD OF MANUFACTURE AND USE IN WATCHMAKING AS AN EPILAME KCNH3, HCN3, HCN4 MAPT 4248/4885HSD17B10 2630/4885ALDH1A1 3248/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.